FR2427331A2 - Derives de l'hydantoine et medicaments contenant ces substances - Google Patents
Derives de l'hydantoine et medicaments contenant ces substancesInfo
- Publication number
- FR2427331A2 FR2427331A2 FR7913823A FR7913823A FR2427331A2 FR 2427331 A2 FR2427331 A2 FR 2427331A2 FR 7913823 A FR7913823 A FR 7913823A FR 7913823 A FR7913823 A FR 7913823A FR 2427331 A2 FR2427331 A2 FR 2427331A2
- Authority
- FR
- France
- Prior art keywords
- substances
- products containing
- medicinal products
- hydantoin derivatives
- hydantoin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940053195 antiepileptics hydantoin derivative Drugs 0.000 title 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical class O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 150000001469 hydantoins Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
- C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
- C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Nouveaux dérivés de l'hydantoïne. Ils sont caractérisés par la formule :
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB25575/78A GB1599740A (en) | 1978-05-31 | 1978-05-31 | Hydantoin derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2427331A2 true FR2427331A2 (fr) | 1979-12-28 |
| FR2427331B2 FR2427331B2 (fr) | 1983-01-28 |
Family
ID=10229898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7913823A Granted FR2427331A2 (fr) | 1978-05-31 | 1979-05-30 | Derives de l'hydantoine et medicaments contenant ces substances |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JPS554371A (fr) |
| AU (1) | AU4762579A (fr) |
| BE (1) | BE876670R (fr) |
| DE (1) | DE2922070A1 (fr) |
| FR (1) | FR2427331A2 (fr) |
| GB (1) | GB1599740A (fr) |
| IL (1) | IL57436A0 (fr) |
| IT (1) | IT1164693B (fr) |
| NL (1) | NL7904311A (fr) |
| SE (1) | SE7904700L (fr) |
| ZA (1) | ZA787354B (fr) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0014076A3 (en) * | 1979-01-18 | 1980-09-17 | Beecham Group Limited | Hydantoin derivatives, their preparation and pharmaceutical compositions |
| CN1084792C (zh) * | 1999-05-31 | 2002-05-15 | 宝山钢铁股份有限公司 | 高风温高炉热风炉空气、煤气预热方法 |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0019223A1 (fr) * | 1979-05-09 | 1980-11-26 | The Wellcome Foundation Limited | Dérivés d'hydantoine optiquement actifs, leur préparation, compositions pharmaceutiques les contenant, et intermédiaires |
| EP0023083A1 (fr) * | 1979-06-27 | 1981-01-28 | Beecham Group Plc | Dérivés d'oxodiazoles, procédés pour leur préparation et composition pharmaceutique les contenant |
| US4908456A (en) * | 1989-04-05 | 1990-03-13 | Takatori Corporation | Process for preparing methylolated hydantoins |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2362839A1 (fr) * | 1976-06-03 | 1978-03-24 | Wellcome Found | Derives de l'hydantoine et medicaments contenant ces substances |
| EP0001238A1 (fr) * | 1977-09-05 | 1979-04-04 | The Wellcome Foundation Limited | Dérivés de l'hydantoine, procédés de préparation, leurs compositions pharmaceutiques et leurs intermédiaires |
-
1978
- 1978-05-31 GB GB25575/78A patent/GB1599740A/en not_active Expired
- 1978-12-28 ZA ZA787354A patent/ZA787354B/xx unknown
-
1979
- 1979-05-30 FR FR7913823A patent/FR2427331A2/fr active Granted
- 1979-05-30 JP JP6740179A patent/JPS554371A/ja active Pending
- 1979-05-30 BE BE0/195494A patent/BE876670R/fr not_active IP Right Cessation
- 1979-05-30 IT IT49253/79A patent/IT1164693B/it active
- 1979-05-30 SE SE7904700A patent/SE7904700L/xx not_active Application Discontinuation
- 1979-05-30 IL IL57436A patent/IL57436A0/xx unknown
- 1979-05-30 AU AU47625/79A patent/AU4762579A/en not_active Abandoned
- 1979-05-30 DE DE19792922070 patent/DE2922070A1/de not_active Withdrawn
- 1979-05-31 NL NL7904311A patent/NL7904311A/xx not_active Application Discontinuation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2362839A1 (fr) * | 1976-06-03 | 1978-03-24 | Wellcome Found | Derives de l'hydantoine et medicaments contenant ces substances |
| EP0001238A1 (fr) * | 1977-09-05 | 1979-04-04 | The Wellcome Foundation Limited | Dérivés de l'hydantoine, procédés de préparation, leurs compositions pharmaceutiques et leurs intermédiaires |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0014076A3 (en) * | 1979-01-18 | 1980-09-17 | Beecham Group Limited | Hydantoin derivatives, their preparation and pharmaceutical compositions |
| CN1084792C (zh) * | 1999-05-31 | 2002-05-15 | 宝山钢铁股份有限公司 | 高风温高炉热风炉空气、煤气预热方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| GB1599740A (en) | 1981-10-07 |
| FR2427331B2 (fr) | 1983-01-28 |
| JPS554371A (en) | 1980-01-12 |
| IL57436A0 (en) | 1979-09-30 |
| IT1164693B (it) | 1987-04-15 |
| AU4762579A (en) | 1979-11-22 |
| ZA787354B (en) | 1980-08-27 |
| IT7949253A0 (it) | 1979-05-30 |
| BE876670R (fr) | 1979-11-30 |
| NL7904311A (nl) | 1979-12-04 |
| SE7904700L (sv) | 1979-12-01 |
| DE2922070A1 (de) | 1979-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2416012A1 (fr) | Derives de l'imidazole et medicament contenant ces substances | |
| FR2392971A1 (fr) | Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances | |
| FR2416234A1 (fr) | Derives de metronidazole et compositions pharmaceutiques en contenant | |
| FR2362839A1 (fr) | Derives de l'hydantoine et medicaments contenant ces substances | |
| FR2367053A1 (fr) | Nouveaux derives de phenoxy-amino-propanol, leur preparation et leur application en tant que medicaments | |
| FR2390420A1 (fr) | Nouveaux derives cyclopeptidiques, leur preparation et leur application comme medicaments | |
| FR2422643A1 (fr) | Nouveaux derives d'imidazolidine, leur preparation et leur application comme medicaments | |
| FR2361901A1 (fr) | Derives de substitution de nucleotides et medicament contenant ces substances | |
| FR2433512A1 (fr) | Derives de l'indane et medicaments qui en contiennent | |
| BE887970A (fr) | Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives | |
| FR2426682A1 (fr) | Derives de l'imidazole et medicaments qui en contiennent | |
| FR2363330A1 (fr) | Medicament destine a reduire la fertilite chez les mammiferes | |
| FR2370744A1 (fr) | Nouveaux derives d'aminopropanol, procede pour leur preparation et medicaments contenant ces composes | |
| FR2377419A1 (fr) | Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament | |
| FR2370745A1 (fr) | Nouveaux derives de la morphanthridine, leur preparation et leur application comme medicaments | |
| FR2415103A1 (fr) | Acides et derives d'acides 4-pyridone-3-carboxyliques, leur preparation et leur application en tant que medicaments | |
| FR2355021A1 (fr) | Nouveaux derives d'imidazothiazine et leur application en tant que medicaments | |
| FR2415636A1 (fr) | Nouveaux derives de la guanidine, leur preparation et leur application comme medicaments | |
| FR2427331A2 (fr) | Derives de l'hydantoine et medicaments contenant ces substances | |
| FR2361361A1 (fr) | Nouveaux derives du cyclopentane et medicaments contenant ces substances | |
| FR2355830A1 (fr) | Nouveaux derives de 6-7-benzomorphane, leur obtention et composition pharmaceutique les contenant | |
| FR2427328A1 (fr) | Ethers diphenyliques et medicament contenant ces substances | |
| OA04707A (fr) | Nouveaux dérivés de l'urée et de l'hydantoïne et compositions régulatrices pour la croissance de plantes. | |
| FR2359857A2 (fr) | Polymeres anti-solaires et compositions cosmetiques les contenant | |
| FR2355012A1 (fr) | Nouveaux derives de dihydro- et tetrahydro-iminothiazine, et leur application en tant que medicaments |